Table 3.

Rate ratios outlining the relative frequency of recommendation for chemotherapy with endocrine therapy or endocrine therapy alone (holding age or health status constant) in a patient with T2N2 hormone-receptor positive, HER2-negative breast cancer.

A. Chemotherapy with endocrine therapy (Reference: Age = 70)
Age	Good	Average	Poor
70	1.00	1.00	1.00
75	0.92	0.85	0.85
80	0.63	0.46	0.34
85	0.30	0.19	0.17

B. Chemotherapy with endocrine therapy (Reference: Health status = Good)
Age	Good	Average	Poor
70	1.00	0.94	0.65
75	1.00	0.87	0.60
80	1.00	0.69	0.35
85	1.00	0.60	0.37